Feasibility and Acceptability of ReCognitionVR-based Cognitive Stimulation in Surgical Patients
2 other identifiers
interventional
30
1 country
1
Brief Summary
This study aims to assess the feasibility, acceptability, and safety of using ReCognitionVR virtual reality-based software in older surgical patients. Results from this study will be used to inform the design of a future study in critically ill hospitalized patients at risk for delirium.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable surgery
Started Dec 2023
Shorter than P25 for not_applicable surgery
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 9, 2023
CompletedFirst Submitted
Initial submission to the registry
January 22, 2024
CompletedFirst Posted
Study publicly available on registry
January 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 21, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 7, 2024
CompletedResults Posted
Study results publicly available
September 17, 2025
CompletedSeptember 17, 2025
August 1, 2025
3 months
January 22, 2024
November 18, 2024
August 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percentage of Patients Experiencing Treatment-emergent Adverse Events (TEAE)
Percentage of participants who experience a treatment-emergent adverse event (TEAE) in the virtual reality software (experimental) arm compared to the Traditional Orientation Methods (control) arm.
Within 1 month of enrolling in the study
Secondary Outcomes (11)
Change From Baseline in Pulse Oximetry Oxygen Saturation After 10 Minutes
Baseline and 10 minutes
Change From Baseline in Respiratory Rate After 10 Minutes
Baseline and 10 minutes
Change From Baseline in Systolic Blood Pressure After 10 Minutes
Baseline and 10 minutes
Change From Baseline in Diastolic Blood Pressure After 10 Minutes
Baseline and 10 minutes
Change From Baseline in Pulse Oximetry Oxygen Saturation After Completion
Baseline and completion of the intervention, up to 2 hours
- +6 more secondary outcomes
Other Outcomes (4)
Percentage of Participants Using Virtual Reality Software at 20 Minutes After Start
20 minutes after the start of software use
Number of Participants With a System Usability Scale (SUS) Score >35
After completion of use of the virtual reality software, up to 2 hours after the start of software use
Proportion of Participants Completing Game With No Errors
After completion of use of the virtual reality software, up to 2 hours after the start of software use
- +1 more other outcomes
Study Arms (2)
Virtual Reality Software
EXPERIMENTALParticipants in this arm will receive cognitive exercises using ReCognitionVR virtual reality software
Traditional Orientation Methods
ACTIVE COMPARATORParticipants in this arm will receive cognitive exercises using traditional (standard-of-care) orientation methods,
Interventions
The ReCognitionVR virtual reality software is delivered via an Oculus Quest 2 device. This three-dimensional simulated software was designed to improve attention and executive functions.
Standard-of-care methods to orient patients after surgery
Eligibility Criteria
You may qualify if:
- ≥60 years of age
- Scheduled to undergo the following abdominal surgeries (open or laparoscopic or robotic assisted): small bowel and large bowel surgery; cholecystectomy; Whipple procedure; pancreatectomy; splenectomy.
- Richmond Agitation-Sedation Scale (RASS) Score 0
You may not qualify if:
- Subjects with baseline cognitive impairment
- Person with active psychiatric disorders and being treated with medications, especially schizophrenia
- Person who is deaf or blind
- Person with an underlying cognitive disorder or associated phobias (e.g., claustrophobia)
- Person participating in other clinical trials involving drugs, biologics, devices, or behavioral interventions
- Active seizure disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Houston Methodist Research Institute
Houston, Texas, 77030, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Hina Faisal
- Organization
- Department of Surgery, Houston Methodist Hospital
Study Officials
- PRINCIPAL INVESTIGATOR
Hina Faisal, MD
The Methodist Hospital Research Institute
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Clinical Surgery
Study Record Dates
First Submitted
January 22, 2024
First Posted
January 30, 2024
Study Start
December 9, 2023
Primary Completion
March 21, 2024
Study Completion
May 7, 2024
Last Updated
September 17, 2025
Results First Posted
September 17, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share